Shakarganj Ltd (SML)
Pakistan Stock Exchange (PSX) · Pakistan · prices in PKR · close of 27 Oct 2026
Key indicators
| Last close | PKR 92.66 |
|---|---|
| 52-week range | 65.00 – 167.42 |
| Return, 1 month / 3 months | −7.3% / −10.9% |
| Return, 1 year / 3 years | +42.6% / – |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 64.6% |
| Worst drawdown (1 year) | -45.4% |
| Average daily value traded | 0.05M PKR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Shakarganj Limited is a public limited company whose main activity is the production of sugar and biofuel, together with the buying and selling of those goods. Sugar is a refined sweetener drawn from cane or beet, while biofuel is a fuel made from biological material such as plant matter. Based in Lahore, the company handles the making and trading of these products as its core business.
On this site Shakarganj Ltd appears as a stock on the Pakistan Stock Exchange (PSX), code SML, with prices in Pakistani rupees (PKR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Shakarganj Ltd (SML) trades on the Pakistan Stock Exchange (PSX) in Pakistan. It last closed at PKR 92.66 on 27 October 2026.
Its price-based Market X-Ray is 26 out of 100 (a weak price profile), ranking 500 of 542 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 42.6% and over the last three months it fell 10.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Pakistan Stock Exchange (PSX)
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 11 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -21.4% | ||
| From 52-week high | -43.8% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.9% | ||
| 6-month return | -31.1% | ||
| 12-month return, skipping the last month | 53.8% | ||
| Stability (higher is calmer) | 30 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 64.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.4% | ||
| Liquidity | 10 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M PKR | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −7.3% |
| 3 months | −10.9% |
| 6 months | −31.1% |
| 1 year | +42.6% |
| 3 years | – |
| 5 years | +81.0% |
Signals
| 50-day / 200-day average | 96.44 / 117.82 |
|---|---|
| Golden / death cross (60 days) | Death, 47 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.29 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Pakistan Stock Exchange (PSX); it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.